About
Synaptic Ventures is a leading venture capital fund dedicated to advancing the field of psychedelic medicine. We focus on identifying and supporting early-stage companies that demonstrate the potential to innovate and transform mental health treatments through psychedelics. By providing not only financial investment but also strategic expertise, we empower our portfolio companies to navigate the complexities of capital markets and achieve sustainable growth. Our commitment to fostering groundbreaking research and developments positions Synaptic Ventures at the forefront of the psychedelic renaissance.